Is Optimal Cytoreduction Post Neoadjuvant Chemotherapy the Only Prognostic Factor in Advanced Ovarian Cancer?

Mostrar otras versiones (1)

Background  Epithelial ovarian cancer (EOC) is one of the leading causes of cancer-related death in women. Approximately 70% of patients with EOC are diagnosed in advanced stage [The International Federation of Gynecology and Obstetrics(FIGO stage III and IV)] with an expected 5-year survival rate o...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhiman, Pravesh, Bapsy, P.P., Patil, C.N., Raghupathi, Renu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803533/
http://dx.doi.org/10.1055/s-0042-1755291
Mostrar todas las versiones(2)

Ejemplares similares